시너지이노베이션
1,462KRWMarket close of 10/20 (Tue)
Down -1.48%-22KRWMarket close of 10/20 (Tue)
- Open
- 1,464
- High
- 1,500
- Low
- 1,462
- Day range
- Day range low 1,462 high 1,500, open 1,464, close 1,462, previous close 1,484
- Volume
- 7×10K shares
- 109.73 million KRW 0.38× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
5%1-year close range 1,406 to 2,635 won, 5% up from the low
5% of the way up from the lowest close in 1 year (252 sessions) · -44.5% from the high
Usual range
Nothing unusual in the 4 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range-1.48%-1.48%, 0.7× the usual (20-session average ±2.04%)That day -1.48% · usual ±2.04% · large-move threshold ±4.1%
The other 3 are within the usual range
- Trading value0.4×usual range
- EarningsOperating income, 8 quarters
- Data date10/20 (Tue)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue27.0B KRW
- vs. year ago
- -0.8%
- vs. prior quarter
- -2.6%
- Operating income3.8B KRW
- vs. year ago
- -20.2%
- vs. prior quarter
- +15.5%
- Operating margin14.1%
- vs. year ago
- -3.4 pp
- vs. prior quarter
- +2.2 pp
Quarterly operating income trend
As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15Same sector · 의료·정밀기기
Down -4.35%· 14 of 100 stocks up, preferred shares excluded · trading value 277.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 빅텍 | Close over the last 20 sessions +15.7% | Up +10.98% | 76.6B KRW |
| 큐리옥스바이오시스템즈 | Close over the last 20 sessions +14.0% | Down -22.08% | 56.8B KRW |
| 케이씨텍 | Close over the last 20 sessions +29.1% | Down -9.36% | 22.5B KRW |
| 티에스이 | Close over the last 20 sessions +8.2% | Down -6.07% | 22.5B KRW |
| 디아이 | Close over the last 20 sessions +13.1% | Down -8.39% | 21.3B KRW |
Schedule
- Next data 10/22 (Thu) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.